Global mAb Biosimilar Market Research Report 2019 by Manufacturers, Regions, Types and Applications

Table of Contents

1 Report Overview

• 1.1 Definition
• 1.2 Manufacturers and Regions Overview
  • 1.2.1 Manufacturers Overview
  • 1.2.2 Regions Overview
• 1.3 Type Overview
• 1.4 Application Overview
• 1.5 Industrial Chain
  • 1.5.1 mAb Biosimilar Overall Industrial Chain
  • 1.5.2 Upstream
  • 1.5.3 Downstream
  • 1.5.4 Economic/Political Environment

2 Global mAb Biosimilar Market Assesment by Types

• 2.1 Overall Market Performance
  • 2.1.1 Product Type Market Performance (Volume)
  • 2.1.2 Product Type Market Performance (Value)
• 2.2 China mAb Biosimilar Market Performance
• 2.3 USA mAb Biosimilar Market Performance
• 2.4 Europe mAb Biosimilar Market Performance
• 2.5 Japan mAb Biosimilar Market Performance
• 2.6 Korea mAb Biosimilar Market Performance
• 2.7 India mAb Biosimilar Market Performance
• 2.8 Southeast Asia mAb Biosimilar Market Performance
• 2.9 South America mAb Biosimilar Market Performance

3 Global mAb Biosimilar Market Assesment by Application

• 3.1 Overall Market Performance (Volume)
• 3.2 China mAb Biosimilar Market Performance (Volume)
• 3.3 USA mAb Biosimilar Market Performance (Volume)
• 3.4 Europe mAb Biosimilar Market Performance (Volume)
• 3.5 Japan mAb Biosimilar Market Performance (Volume)
• 3.6 Korea mAb Biosimilar Market Performance (Volume)
• 3.7 India mAb Biosimilar Market Performance (Volume)
• 3.8 Southeast Asia mAb Biosimilar Market Performance (Volume)
• 3.9 South America mAb Biosimilar Market Performance (Volume)

4 Competitive Analysis

• 4.1 Baxter
  • 4.1.1 Baxter Profiles
  • 4.1.2 Baxter Product Information
  • 4.1.3 Baxter mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.1.4 Baxter mAb Biosimilar Business Performance
  • 4.1.5 SWOT Analysis
• 4.2 GSK
  • 4.2.1 GSK Profiles
  • 4.2.2 GSK Product Information
  • 4.2.3 GSK mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.2.4 GSK mAb Biosimilar Business Performance
  • 4.2.5 SWOT Analysis
• 4.3 Merck
  • 4.3.1 Merck Profiles
  • 4.3.2 Merck Product Information
  • 4.3.3 Merck mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.3.4 Merck mAb Biosimilar Business Performance
  • 4.3.5 SWOT Analysis
• 4.4 Novartis
  • 4.4.1 Novartis Profiles
  • 4.4.2 Novartis Product Information
  • 4.4.3 Novartis mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.4.4 Novartis mAb Biosimilar Business Performance
  • 4.4.5 SWOT Analysis
• 4.5 Pfizer
  • 4.5.1 Pfizer Profiles
  • 4.5.2 Pfizer Product Information
  • 4.5.3 Pfizer mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.5.4 Pfizer mAb Biosimilar Business Performance
  • 4.5.5 SWOT Analysis
• 4.6 Roche Holding
  • 4.6.1 Roche Holding Profiles
  • 4.6.2 Roche Holding Product Information
  • 4.6.3 Roche Holding mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.6.4 Roche Holding mAb Biosimilar Business Performance
  • 4.6.5 SWOT Analysis
• 4.7 Sanofi
  • 4.7.1 Sanofi Profiles
  • 4.7.2 Sanofi Product Information
  • 4.7.3 Sanofi mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.7.4 Sanofi mAb Biosimilar Business Performance
  • 4.7.5 SWOT Analysis
• 4.8 Mitsubishi Tanabe Pharma
  • 4.8.1 Mitsubishi Tanabe Pharma Profiles
  • 4.8.2 Mitsubishi Tanabe Pharma Product Information
  • 4.8.3 Mitsubishi Tanabe Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.8.4 Mitsubishi Tanabe Pharma mAb Biosimilar Business Performance
  • 4.8.5 SWOT Analysis
• 4.9 Hospira
  • 4.9.1 Hospira Profiles
  • 4.9.2 Hospira Product Information
  • 4.9.3 Hospira mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.9.4 Hospira mAb Biosimilar Business Performance
  • 4.9.5 SWOT Analysis
• 4.10 Alvartis Pharma
  • 4.10.1 Alvartis Pharma Profiles
  • 4.10.2 Alvartis Pharma Product Information
  • 4.10.3 Alvartis Pharma mAb Biosimilar Production, Revenue, Price and Gross Margin
  • 4.10.4 Alvartis Pharma mAb Biosimilar Business Performance
  • 4.10.5 SWOT Analysis
• 4.11 Allergan
• 4.12 Amega Biotech
• 4.13 Biogen
• 4.14 LG Lifesciences
• 4.15 Samsung Biologics

5 Competitive Landscape

• 5.1 Global mAb Biosimilar Production (K Pcs) and Market Share by Manufacturers (2014-2019)
• 5.2 Global mAb Biosimilar Revenue (M USD) and Market Share by Manufacturers (2014-2019)
• 5.3 Global mAb Biosimilar Price (USD/Pcs) of Manufacturers (2014-2019)
• 5.4 Global mAb Biosimilar Gross Margin of Manufacturers (2014-2019)
• 5.5 Market Concentration

6 Global mAb Biosimilar Market Assessment by Regions

• 6.1 Global mAb Biosimilar Production (K Pcs) and Market Share by Regions (2014-2019)
• 6.2 Global mAb Biosimilar Revenue (M USD) and Market Share by Regions (2014-2019)
• 6.3 Global mAb Biosimilar Price (USD/Pcs) by Regions (2014-2019)
• 6.4 Global mAb Biosimilar Gross Margin by Regions (2014-2019)

7 mAb Biosimilar Regional Analysis

• 7.1 China mAb Biosimilar Production, Revenue and Growth Rate (2014-2019)
• 7.2 USA mAb Biosimilar Production, Revenue and Growth Rate (2014-2019)
• 7.3 Europe mAb Biosimilar Production, Revenue and Growth Rate (2014-2019)
• 7.4 Japan mAb Biosimilar Production, Revenue and Growth Rate (2014-2019)
• 7.5 Korea mAb Biosimilar Production, Revenue and Growth Rate (2014-2019)
• 7.6 India mAb Biosimilar Production, Revenue and Growth Rate (2014-2019)
• 7.7 Southeast Asia mAb Biosimilar Production, Revenue and Growth Rate (2014-2019)
• 7.8 South America mAb Biosimilar Production, Revenue and Growth Rate (2014-2019)

8 Global mAb Biosimilar Consumption Assessment

• 8.1 Global mAb Biosimilar Consumption and Market Share by Regions (2014-2019)
• 8.2 Global mAb Biosimilar Consumption Value and Market Share by Regions (2014-2019)
• 8.3 Global mAb Biosimilar Average Price (USD/Pcs) by Regions (2014-2019)

9 Global mAb Biosimilar Sales Assessment by Regions

• 9.1 Global mAb Biosimilar Sales and Sales Value (2014-2019)
• 9.2 China mAb Biosimilar Sales and Sales Value (2014-2019)
• 9.3 USA mAb Biosimilar Sales and Sales Value (2014-2019)
• 9.4 Europe mAb Biosimilar Sales and Sales Value (2014-2019)
• 9.5 Japan mAb Biosimilar Sales and Sales Value (2014-2019)
• 9.6 Korea mAb Biosimilar Sales and Sales Value (2014-2019)
• 9.7 India mAb Biosimilar Sales and Sales Value (2014-2019)
• 9.8 Southeast Asia mAb Biosimilar Sales and Sales Value (2014-2019)
• 9.9 South America mAb Biosimilar Sales and Sales Value (2014-2019)

10 Technology and Cost

• 10.1 Technology
• 10.2 Cost

11 Channel Analysis

• 11.1 Market Channel
• 11.2 Distributors

12 Market Forecast 2020-2025

• 12.1 Production and Revenue Forecast 2020-2025
  • 12.1.1 Global mAb Biosimilar Production and Revenue by Regions 2020-2025
  • 12.1.2 China mAb Biosimilar Production, Revenue and Growth Rate 2020-2025
  • 12.1.3 USA mAb Biosimilar Production, Revenue and Growth Rate 2020-2025
  • 12.1.4 Europe mAb Biosimilar Production, Revenue and Growth Rate 2020-2025
  • 12.1.5 Japan mAb Biosimilar Production, Revenue and Growth Rate 2020-2025
  • 12.1.6 Korea mAb Biosimilar Production, Revenue and Growth Rate 2020-2025
  • 12.1.7 India mAb Biosimilar Production, Revenue and Growth Rate 2020-2025
  • 12.1.8 Southeast Asia mAb Biosimilar Production, Revenue and Growth Rate 2020-2025
  • 12.1.9 South America mAb Biosimilar Production, Revenue and Growth Rate 2020-2025
• 12.2 Sales and Sales Value Forecast 2020-2025
  • 12.2.1 Global mAb Biosimilar Consumption and Consumption Calue by Regions 2020-2025
  • 12.2.2 Global mAb Biosimilar Sales and Sales Value Forecast 2020-2025
  • 12.2.3 China mAb Biosimilar Sales, Sales Value and Growth Rate 2020-2025
  • 12.2.4 USA mAb Biosimilar Sales and Sales Value Forecast 2020-2025
  • 12.2.5 Europe mAb Biosimilar Sales and Sales Value Forecast 2020-2025
  • 12.2.6 Japan mAb Biosimilar Sales and Sales Value Forecast 2020-2025
  • 12.2.7 Korea mAb Biosimilar Sales and Sales Value Forecast 2020-2025
  • 12.2.8 India mAb Biosimilar Sales and Sales Value Forecast 2020-2025
  • 12.2.9 Southeast Asia mAb Biosimilar Sales and Sales Value Forecast 2020-2025
  • 12.2.10 South America mAb Biosimilar Sales and Sales Value Forecast 2020-2025
• 12.3 Global mAb Biosimilar Production and Revenue Forecast by Type 2020-2025
  • 12.3.1 Overall Market Performance
  • 12.3.2 Type I
  • 12.3.3 Type II
  • 12.3.4 Type III
• 12.4 Global mAb Biosimilar Sales Forecast by Application 2020-2025
  • 12.4.1 Overall Market Performance
  • 12.4.2 Application 1
  • 12.4.3 Application 2
  • 12.4.4 Application 3
• 12.5 Global mAb Biosimilar Price and Gross Margin Forecast
  • 13.5.1 Global mAb Biosimilar Averages Price Development Trend Forecast 2020-2025
  • 13.5.2 Global mAb Biosimilar Gross Margin Development Trend Forecast 2020-2025

13 Conclusion